Advancing the Promise of Cell and Gene Therapies

Cell and gene therapies are providing remarkable outcomes for patients in need of new treatment options. To bring these promising modalities to more patients, advances are needed across the continuum from discovery through development to manufacturing.  

That’s where we can make a difference. We’re committed to helping you reveal the full potential of cell therapies, gene-modified cell therapies, and gene therapies. Let’s get started.

The Finish Line. Faster.

How Scalable and Intensified is Your CAR-T Process?

The clinical pipeline for CAR-T therapy shows the imminent need for manufacturing optimization to overcome key bottlenecks.

Learn More

New Facility for Viral Vector Production

Improved manufacturing capacity can increase the speed that new products are made available to patients.

Learn More

Digitalize Your Cell and Gene Therapy Processes

CDMOs can address key process optimization challenges and improve delivery time for cell and gene therapies using data analytics.

Learn More
Sartorius Gene-Modified Cell Therapy Solutions

Explore Sartorius

icon-light-bulb-on

Process Development Knowledge

Learn More
icon-rocket

Gene Therapy Resources

Learn More
icon-target

iPSC Solutions

Learn More